MedPath
HSA Approval

TALVEY SOLUTION FOR INJECTION 40MG/ML

SIN17142P

TALVEY SOLUTION FOR INJECTION 40MG/ML

TALVEY SOLUTION FOR INJECTION 40MG/ML

November 15, 2024

JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

L01FX29

Manufacturer Information

JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD.

Patheon Manufacturing Services LLC

Active Ingredients

Talquetamab

40mg/mL

Talquetamab

Documents

Package Inserts

TALVEY Solution for Injection PI.pdf

Approved: November 15, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TALVEY SOLUTION FOR INJECTION 40MG/ML - HSA Approval | MedPath